Airsculpt Technologies (AIRS) experienced a significant pre-market plunge of 11.82% on Friday, as investors brace for the company's third-quarter earnings report scheduled for release at 6:00 AM. The sharp decline suggests that market participants may be anticipating disappointing results from the aesthetic surgery company.

According to analyst estimates, Airsculpt is expected to report a loss of $0.02 per share for the quarter. This projection of negative earnings appears to be fueling investor concerns, leading to the substantial sell-off in pre-market trading. The company's performance in this earnings report could be crucial in determining its near-term stock trajectory.

The pre-market plunge highlights the high stakes surrounding Airsculpt's upcoming financial disclosure. Investors will be closely watching key metrics such as revenue growth, patient volumes, and any guidance provided by management for future quarters. The aesthetic surgery industry has faced challenges in recent times, including economic uncertainties and changes in consumer spending patterns, which may have impacted Airsculpt's operations.